Picture of Biomx logo

PHGE Biomx Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Biomx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-30.1-36.2-28.3-26.2-17.7
Depreciation
Non-Cash Items3.012.981.131.54-18.1
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.4533.1-4.432.48-2.99
Change in Accounts Receivable
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-24.4-27.6-29.1-21.3-37
Capital Expenditures-1.01-3.68-0.112-0.05-0.03
Purchase of Fixed Assets
Other Investing Cash Flow Items-9.8519.9-220.745
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Cash from Investing Activities-10.916.2-2.111.950.715
Financing Cash Flow Items-0.075-0.33320.4
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.13437.30.2922.938.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-35.225.9-30.8-16.42.11